Variation in metabolic and cardiovascular risk in women with different polycystic ovary syndrome phenotypes

被引:78
|
作者
Wiltgen, Denusa
Spritzer, Poli Mara [1 ]
机构
[1] Hosp Clin Porto Alegre, Div Endocrinol, Gynecol Endocrinol Unit, BR-90035003 Porto Alegre, RS, Brazil
关键词
IMPAIRED GLUCOSE-TOLERANCE; INSULIN-RESISTANCE; PREVALENCE; FEATURES; PCOS; ACCUMULATION; PREDICTORS; HIRSUTISM; INDEX;
D O I
10.1016/j.fertnstert.2010.02.015
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
The aim of this study was to compare clinical, hormonal, and metabolic variables in women with classic polycystic ovary syndrome (PCOS), in ovulatory women presenting hirsutism, normal androgen levels, and polycystic ovaries (H+PCO), and in a group with isolated hirsutism (IH) presenting with normal ovaries and androgen levels. Waist circumference, triglycerides, and homeostasis model assessment values were significantly higher in classic PCOS even after adjustment for body mass index, and metabolic syndrome was three times more frequent in classic PCOS than in H+PCO or IH (31.3% vs. 11.9% vs. 9%), but no differences were observed regarding metabolic profile and cardiovascular risk factors between the H+PCO and IH groups, which presented with significantly more metabolic syndrome than normal controls when only overweight and obese women were considered. (Fertil Steril (R) 2010;94:2493-6. (c) 2010 by American Society for Reproductive Medicine.)
引用
收藏
页码:2493 / 2496
页数:4
相关论文
共 50 条
  • [21] Elevated fasting insulin is associated with cardiovascular and metabolic risk in women with polycystic ovary syndrome
    Rasool, Shayaq Ul Abeer
    Ashraf, Sairish
    Nabi, Mudasar
    Rashid, Fouzia
    Fazili, Khalid Majid
    Amin, Shajrul
    [J]. DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2019, 13 (03) : 2098 - 2105
  • [22] The effects of metformin on metabolic and cardiovascular risk factors in nonobese women with polycystic ovary syndrome
    Sahin, Yilmaz
    Unluhizarci, Kursad
    Yilmazsoy, Ayse
    Yikilmaz, Ali
    Aygen, Ercan
    Kelestimur, Fahrettin
    [J]. CLINICAL ENDOCRINOLOGY, 2007, 67 (06) : 904 - 908
  • [23] Role of androgen excess on metabolic aberrations and cardiovascular risk in women with polycystic ovary syndrome
    Christakou, Charikleia D.
    Diamanti-Kandarakis, Evanthia
    [J]. WOMENS HEALTH, 2008, 4 (06) : 583 - 594
  • [24] Cardiovascular disease risk characteristics of the main polycystic ovary syndrome phenotypes
    Dilbaz, Berna
    Ozkaya, Enis
    Cinar, Mehmet
    Cakir, Evrim
    Dilbaz, Serdar
    [J]. ENDOCRINE, 2011, 39 (03) : 272 - 277
  • [25] Polycystic ovary syndrome: cardiovascular risk factors according to specific phenotypes
    Aziz, Mubeena
    Sidelmann, Johannes J.
    Faber, Jens
    Wissing, Marie-Louise. M.
    Naver, Klara V.
    Mikkelsen, Anne-Lis
    Nilas, Lisbeth
    Skouby, Sven O.
    [J]. ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 2015, 94 (10) : 1082 - 1089
  • [26] Cardiovascular disease risk characteristics of the main polycystic ovary syndrome phenotypes
    Berna Dilbaz
    Enis Özkaya
    Mehmet Cinar
    Evrim Cakir
    Serdar Dilbaz
    [J]. Endocrine, 2011, 39 : 272 - 277
  • [27] Is the Risk for Cardiovascular Disease Increased in all Phenotypes of the Polycystic Ovary Syndrome?
    Daskalopoulos, Georgios N.
    Karkanaki, Artemis
    Karagiannis, Asterios
    Mikhailidis, Dimitri P.
    Athyros, Vasilios G.
    [J]. ANGIOLOGY, 2011, 62 (04) : 285 - 290
  • [28] Excess Metabolic and Cardiovascular Risk is not Manifested in all Phenotypes of Polycystic Ovary Syndrome: Implications for Diagnosis and Treatment
    Daskalopoulos, Georgios
    Karkanaki, Artemis
    Piouka, Athanasia
    Prapas, Nikolaos
    Panidis, Dimitrios
    Gkeleris, Paraschos
    Athyros, Vasilios G.
    [J]. CURRENT VASCULAR PHARMACOLOGY, 2015, 13 (06) : 788 - 800
  • [29] The Role of Different Methods in Defining Cardiometabolic Risk and Metabolic Syndrome in Women with Polycystic Ovary Syndrome
    Bicer, Nihan Cakir
    Ermis, Asime Aleyna
    Bas, Dilsat
    [J]. LIFE-BASEL, 2023, 13 (10):
  • [30] Assisted reproductive outcomes in women with different polycystic ovary syndrome phenotypes
    Eftekhar, Maryam
    Mirhashemi, Elham S.
    Tabibnejad, Nasim
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2019, 144 (02) : 147 - 152